The Vanguard Study: Assessing feasibility of conducting randomized trials of novel multi-cancer detection tests.

Guthrie KA, Anderson GL, Bell-Brown A, Cook LS, Doescher MP, Etzioni RB, Feng Z, Henderson LM, Herman J, Honda SA, James AS, Kaltman R, Kooperberg C, Krist AH, Lee CB, Lee JK, LeeVan E, Liao JC, Minasian LM, Moore KN, Nana-Sinkam P, Natale KE, Neslund-Dudas C, Ngo-Metzger Q, Ong MJC, Oshiro CES, Park Y, Patriotis C, Pinsky P, Prorok PC, Reuland DS, Ritzwoller DP, Rubinstein WS, Sakoda LC, Sayles J, Schenk JM, Shofer S, Simoff M, Toriola AT, White L, Wion ES, Wood M, Ramsey SD

Open source

DOI: 10.1016/j.cct.2026.108418
Published: 2026 Oct
Container: Contemporary clinical trials
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.cct.2026.108418,
  title = {The Vanguard Study: Assessing feasibility of conducting randomized trials of novel multi-cancer detection tests.},
  author = {Guthrie KA and Anderson GL and Bell-Brown A and Cook LS and Doescher MP and Etzioni RB and Feng Z and Henderson LM and Herman J and Honda SA and James AS and Kaltman R and Kooperberg C and Krist AH and Lee CB and Lee JK and LeeVan E and Liao JC and Minasian LM and Moore KN and Nana-Sinkam P and Natale KE and Neslund-Dudas C and Ngo-Metzger Q and Ong MJC and Oshiro CES and Park Y and Patriotis C and Pinsky P and Prorok PC and Reuland DS and Ritzwoller DP and Rubinstein WS and Sakoda LC and Sayles J and Schenk JM and Shofer S and Simoff M and Toriola AT and White L and Wion ES and Wood M and Ramsey SD},
  year = {2026},
  journal = {Contemporary clinical trials},
  doi = {10.1016/j.cct.2026.108418},
  url = {https://doi.org/10.1016/j.cct.2026.108418}
}

RIS

TY  - JOUR
TI  - The Vanguard Study: Assessing feasibility of conducting randomized trials of novel multi-cancer detection tests.
AU  - Guthrie KA
AU  - Anderson GL
AU  - Bell-Brown A
AU  - Cook LS
AU  - Doescher MP
AU  - Etzioni RB
AU  - Feng Z
AU  - Henderson LM
AU  - Herman J
AU  - Honda SA
AU  - James AS
AU  - Kaltman R
AU  - Kooperberg C
AU  - Krist AH
AU  - Lee CB
AU  - Lee JK
AU  - LeeVan E
AU  - Liao JC
AU  - Minasian LM
AU  - Moore KN
AU  - Nana-Sinkam P
AU  - Natale KE
AU  - Neslund-Dudas C
AU  - Ngo-Metzger Q
AU  - Ong MJC
AU  - Oshiro CES
AU  - Park Y
AU  - Patriotis C
AU  - Pinsky P
AU  - Prorok PC
AU  - Reuland DS
AU  - Ritzwoller DP
AU  - Rubinstein WS
AU  - Sakoda LC
AU  - Sayles J
AU  - Schenk JM
AU  - Shofer S
AU  - Simoff M
AU  - Toriola AT
AU  - White L
AU  - Wion ES
AU  - Wood M
AU  - Ramsey SD
PY  - 2026
JO  - Contemporary clinical trials
DO  - 10.1016/j.cct.2026.108418
UR  - https://doi.org/10.1016/j.cct.2026.108418
ER  -

APA

KA, G., GL, A., A, B., LS, C., MP, D., RB, E., Z, F., LM, H., J, H., SA, H., AS, J., R, K., C, K., AH, K., CB, L., JK, L., E, L., JC, L., LM, M., KN, M., P, N., KE, N., C, N., Q, N., MJC, O., CES, O., Y, P., C, P., P, P., PC, P., DS, R., DP, R., WS, R., LC, S., J, S., JM, S., S, S., M, S., AT, T., L, W., ES, W., M, W., & SD, R. (2026). The Vanguard Study: Assessing feasibility of conducting randomized trials of novel multi-cancer detection tests.. Contemporary clinical trials. https://doi.org/10.1016/j.cct.2026.108418

Source records

pubmed · retrieved 2026-09-25T05:00:35.702Z